Oncology Hematology Associates of Central Illinois, PC - Peoria

Peoria, Illinois, United States
Cancer treatment center in Peoria, Illinois
8940 Wood Sage Rd, Peoria, IL 61615

About Oncology Hematology Associates of Central Illinois, PC - Peoria


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Alliance for Clinical Trials in Oncology
90
National Cancer Institute (NCI)
56
SWOG Cancer Research Network
21
University of Chicago
16
Eastern Cooperative Oncology Group
14
Radiation Therapy Oncology Group
12
ECOG-ACRIN Cancer Research Group
10
NSABP Foundation Inc
9
GOG Foundation
2
Genentech, Inc.
2
University Health Network, Toronto
2
Total Rows: 29

Clinical Trials at Oncology Hematology Associates of Central Illinois, PC - Peoria


During the past decade, Oncology Hematology Associates of Central Illinois, PC - Peoria conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 127 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 23 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma
1997-09-01
Completed
40
Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus
1998-03-01
2003-08-01
Completed
15
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma
1998-11-01
2011-07-01
Completed
29
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
1998-10-01
2004-10-01
Completed
1,691
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1998-10-01
2016-12-01
Completed
682
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
1999-12-01
2022-05-20
Completed
636
Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer
2000-01-01
2005-01-01
Completed
16

Rows per page:

1–100 of 252

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Oncology Hematology Associates of Central Illinois, PC - Peoria" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 90 trials, followed by "National Cancer Institute (NCI)" with 56 trials sponsored, "SWOG Cancer Research Network" with 21 trials sponsored, "University of Chicago" with 16 trials sponsored and "Eastern Cooperative Oncology Group" with 16 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 29 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Hematology Associates of Central Illinois, PC - Peoria" #1 collaborator was "National Cancer Institute (NCI)" with 182 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "NCIC Clinical Trials Group" with 13 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator and "Eastern Cooperative Oncology Group" with 10 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 30 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAlliance for ClinicalTrials in Oncology: 90Alliance for ClinicalTrials in Oncology: 90National CancerInstitute (NCI): 56National CancerInstitute (NCI): 56SWOG Cancer ResearchNetwork: 21SWOG Cancer ResearchNetwork: 21University of Chicago: 16University of Chicago: 16Eastern CooperativeOncology Group: 14Eastern CooperativeOncology Group: 14Radiation TherapyOncology Group: 12Radiation TherapyOncology Group: 12ECOG-ACRIN CancerResearch Group: 10ECOG-ACRIN CancerResearch Group: 10NSABP Foundation Inc: 9NSABP Foundation Inc: 9GOG Foundation: 2GOG Foundation: 2Genentech, Inc.: 2Genentech, Inc.: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 182National CancerInstitute (NCI): 182NRG Oncology: 14NRG Oncology: 14NCIC Clinical Trials Group: 13NCIC Clinical Trials Group: 13Cancer and LeukemiaGroup B: 12Cancer and LeukemiaGroup B: 12Eastern CooperativeOncology Group: 10Eastern CooperativeOncology Group: 10SWOG Cancer ResearchNetwork: 10SWOG Cancer ResearchNetwork: 10North Central CancerTreatment Group: 9North Central CancerTreatment Group: 9Radiation TherapyOncology Group: 3Radiation TherapyOncology Group: 3American College ofSurgeons: 2American College ofSurgeons: 2Bayer: 2Bayer: 2

Clinical Trials Conditions at Oncology Hematology Associates of Central Illinois, PC - Peoria


According to Clinical.Site data, the most researched conditions in "Oncology Hematology Associates of Central Illinois, PC - Peoria" are "Breast Cancer" (41 trials), "Lung Cancer" (24 trials), "Lymphoma" (19 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (12 trials) and "Colorectal Cancer" (11 trials). Many other conditions were trialed in "Oncology Hematology Associates of Central Illinois, PC - Peoria" in a lesser frequency.

Clinical Trials Intervention Types at Oncology Hematology Associates of Central Illinois, PC - Peoria


Most popular intervention types in "Oncology Hematology Associates of Central Illinois, PC - Peoria" are "Drug" (216 trials), "Other" (94 trials), "Biological" (80 trials), "Radiation" (40 trials) and "Procedure" (17 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (38 trials), "placebo" (35 trials), "carboplatin" (18 trials), "Bevacizumab" (17 trials) and "Paclitaxel" (15 trials). Other intervention names were less common.

Clinical Trials Genders at Oncology Hematology Associates of Central Illinois, PC - Peoria


The vast majority of trials in "Oncology Hematology Associates of Central Illinois, PC - Peoria" are 201 trials for "All" genders, 43 trials for "Female" genders and 7 trials for "Male" genders.

Clinical Trials Status at Oncology Hematology Associates of Central Illinois, PC - Peoria


Currently, there are NaN active trials in "Oncology Hematology Associates of Central Illinois, PC - Peoria". undefined are not yet recruiting, 1 are recruiting, 51 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 182 completed trials in Oncology Hematology Associates of Central Illinois, PC - Peoria, undefined suspended trials, and 15 terminated clinical trials to date.
Out of the total trials that were conducted in Oncology Hematology Associates of Central Illinois, PC - Peoria, 16 "Phase 1" clinical trials were conducted, 127 "Phase 2" clinical trials and 110 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 127Phase 2: 127Phase 3: 110Phase 3: 110Phase 1: 16Phase 1: 16Not Applicable: 3Not Applicable: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 182Completed: 182Active, not recruiting: 51Active, not recruiting: 51Terminated: 15Terminated: 15Unknown status: 3Unknown status: 3Recruiting: 1Recruiting: 1